Monobenzone
Back to searchMolecule Structure
Scientific Name
Monobenzone
Description of the Drug
Monobenzone is a hydroquinone derivative used to treat vitiligo.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00600
http://www.drugbank.ca/drugs/DB00600
Brand Name(s)
Benoquin
Company Owner(s)
Valeant Pharmaceuticals International
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Tyrosinase | SINGLE PROTEIN | INHIBITOR | CHEMBL1973 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL35631 | |
PharmGKB | PA164764582 | |
Human Metabolome Database | HMDB0014738 | |
DrugBank | DB00600 | |
PubChem: Thomson Pharma | 15114599 | |
PubChem | 7638 | |
Mcule | MCULE-6689165962 | |
LINCS | LSM-5642 | |
Nikkaji | J5.012A | |
BindingDB | 50410520 | |
EPA CompTox Dashboard | DTXSID2020717 | |
DrugCentral | 1834 | |
Brenda | 108379 | 25435 |
ChemicalBook | CB2156828 | |
Guide to Pharmacology | 6830 | |
rxnorm | MONOBENZONE | |
KEGG Ligand | C14244 | |
ChEBI | 34380 | |
ZINC | ZINC000000001748 |